Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case–control study

BACKGROUND: This study aimed to evaluate the long-term outcome and toxicities in patients with locoregionally advanced nasopharyngeal carcinoma (NPC) treated by concurrent chemoradiotherapy (CCRT) with/without adding cetuximab. METHODS: A total of 62 patients treated with CCRT plus cetuximab were ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Chen, Qiu-Yan, Tang, Lin-Quan, Liu, Li-Ting, Guo, Shan-Shan, Guo, Ling, Mo, Hao-Yuan, Chen, Ming-Yuan, Guo, Xiang, Cao, Ka-Jia, Qian, Chao-Nan, Zeng, Mu-Shen, Bei, Jin-Xin, Shao, Jian-Yong, Sun, Ying, Tan, Jing, Chen, Shuai, Ma, Jun, Zhao, Chong, Mai, Hai-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571586/
https://www.ncbi.nlm.nih.gov/pubmed/28836950
http://dx.doi.org/10.1186/s12885-017-3552-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571586/
https://www.ncbi.nlm.nih.gov/pubmed/28836950
http://dx.doi.org/10.1186/s12885-017-3552-6

Ejemplares similares